As of May 22
| -0.14 / -1.83%|
The 2 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 12.00. The median estimate represents a +73.56% increase from the last price of 7.49.
The current consensus among 4 polled investment analysts is to Buy stock in ChemoCentryx Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.